MANITOWOC CO INC 8-K

What Happened

• The Manitowoc Company, Inc. announced that at its May 5, 2026 Annual Meeting shareholders approved the 2025 Omnibus Incentive Plan as Amended and Restated (the “Amended and Restated Omnibus Plan”), effective May 5, 2026. The company filed the 8-K on May 6, 2026.
• Approval included contingent equity awards to the company’s named executive officers as described in the company’s definitive Proxy Statement filed March 20, 2026.

Key Details

• Share authorization: approval added 1,800,000 shares, bringing the total available under the plan to 3,600,000 shares of common stock.
• Incentive stock options: up to 3,600,000 shares may be issued upon exercise of incentive stock options.
• Award types: plan permits stock options, SARs, restricted stock/units, performance shares/units, cash incentives and dividend equivalents for officers, employees, directors, consultants and advisors.
• Term and control: no awards may be granted after the 10th anniversary of shareholder approval (i.e., after May 5, 2036); the Board or plan administrator may terminate the plan at any time.

Why It Matters

• Approval increases the number of shares available for employee and executive compensation, which can align management and shareholder interests but also represents potential future dilution if awards are granted and exercised.
• The filing confirms contingent equity grants to named executives were approved, which is material for assessing executive pay and incentives disclosed in the company’s proxy.
• Investors should review the March 20, 2026 proxy (and Exhibit 10.1 to the 8-K) for full details on award sizing, performance conditions and the disclosed “New Plan Benefits” to understand timing and potential dilution impact.